Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation
Purpose. To assess the cost-effectiveness of bevacizumab compared to ranibizumab, verteporfin photodynamic therapy (PDT), and usual care for the treatment of age-related macular degeneration (AMD) in China. Methods. A Markov model was developed according to patient visual acuity (VA) in the better-s...
Main Authors: | Bin Wu, Jin Li, Houwen Lin, Haixiang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2016/7689862 |
Similar Items
-
Progress in the treatment of neovascular age-related macular degeneration
by: Ya-Xin Wang, et al.
Published: (2021-10-01) -
Age-related macular degeneration: current treatments
by: Jean Pierre Hubschman, et al.
Published: (2009-01-01) -
The pathogenesis and antioxidant treatment of age-related macular degeneration
by: Zi-Wen Sun, et al.
Published: (2020-03-01) -
Regional differences in the global burden of age-related macular degeneration
by: Xiayan Xu, et al.
Published: (2020-03-01) -
Age-related macular degeneration
by: Wanjiku Mathenge
Published: (2014-12-01)